C12Y 601/01003
Threonine-trna ligase
Official title: Threonine-tRNA ligase (6.1.1.3)
C12Y601/01003 (Threonine-trna ligase) appears on 10 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 8
- Assignees
- 7
- Inventors
- 22
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 3 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 3 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TARS derived from Akkermansia muciniphila or fragment thereof, and use thereof26 May 2026US 12,636,342 B2Korea Research Institute of Bioscience and Biotechnology
- Methods and compounds for reducing threonyl-tRNA synthetase activity18 Jan 2022US 11,225,653 B2University of Vermont and State Agricultural College
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases18 Feb 2020US 10,563,192 B2aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases11 Dec 2018US 10,150,958 B2aTyr Pharma, Inc.
- Methods and compounds for increasing threonyl-tRNA synthetase activity13 Nov 2018US 10,125,358 B2University of Vermont and State Agricultural College
- Tars derived from akkermansia muciniphila or fragment thereof, and use thereof26 Jan 2023US 2023/0024893 A1Korea Research Institute of Bioscience and Biotechnology
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases18 Jul 2019US 2019/0218542 A1aTyr Pharma, Inc.
- Methods and compounds for reducing threonyl-trna synthetase activity28 Feb 2019US 2019/0062722 A1University of Vermont and State Agricultural College
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases31 Aug 2017US 2017/0246296 A1aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases8 Oct 2015US 2015/0284706 A1aTyr Pharma, Inc.
Most cited
By later US patents
- DNA encoding threonyl tRNA synthetase from staphylococcus aureus73US 5,795,757 ASmithKline Beecham Corporation · 1998
- Threonyl tRNA synthetase from Staphylococcus aureus67US 5,928,920 ASmithKline Beecham Corporation · 1999
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases11US 8,986,681 B2aTyr Pharma, Inc. · 2015
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases3US 9,580,706 B2aTyr Pharma, Inc. · 2017
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases1US 10,150,958 B2aTyr Pharma, Inc. · 2018